MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today...
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today...
RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience....
Partnership builds on Metro ENT’s established physician leadership while adding the resources and infrastructure of the National Breathe Free network.MESQUITE,...
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD...
Third-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure...
Transcom's Retail Peak Resilience Index finds cost per order can triple while order volume doubles in operating models tuned to...
- New analyses from the pivotal Launch-HTN trial showed that 46% of participants with difficult-to-treat hypertension receiving lorundrostat 50 mg...
Shares expected to begin trading on split-adjusted basis on October 14, 2026LONG BEACH, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) --...
Communication with FDA at recent Type B meeting provided clear guidance for next steps to prepare IND application to support...
Veteran retina commercial leader, who has helped launch BEOVU®, EYLEA® and EYLEA® HD, to lead U.S. commercialization of LYTENAVA™ (bevacizumab-vikg)ISELIN,...
Research presented at ISFTD 2026 connects measurements from the living brain with disease patterns confirmed through postmortem analysis Mapping cortical...
AUSTIN, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company...
Company common stock to trade on Nasdaq under the symbol “IRLA” effective October 12, 2026 Key Management changes include new...
VANCOUVER, British Columbia, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage...
Presentation of data from the INTEGUMENT-INFANT trial of investigational ZORYVE cream 0.05% in infants ages 3 to <24 months, where...
Specialty practices gain a choice of two leading AI patient access platforms, unveiled at AAO 2026 in New OrleansTAMPA, Fla.,...
Fort Lee, NJ, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Dutch Cardiovascular Investigator Network (WCN) Leads European Enrollment in Phase 3 Study Evaluating Etripamil Nasal Spray for AFib-RVRMONTREAL and CHARLOTTE, N.C., Oct....
Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s...
OTTAWA, Ontario, Oct. 09, 2026 (GLOBE NEWSWIRE) -- With Halloween approaching, Dr. Mark Northcott, co-founder of Trillium Dental and a...